Published: 7 September 2023
Publications
Quarterly summary of recent safety communications
Published: 7 September 2023
Prescriber Update 44(3): 49
September 2023
The table below is a summary of recent safety communications for healthcare professionals and consumers. Click on a specific topic to go to the communication.
Date | Communication | Topic |
---|---|---|
10/08/2023 | Dear Healthcare Professional Letter | Estradiol Transdermal Patches (Mylan) – Alternative Registered Carton (PDF, 3 pages, 506 KB) |
07/08/2023 | Consultation | Clozapine Survey 2023 (closes 6 October 2023) |
04/07/2023 | Dear Healthcare Professional Letter | Estradiol Transdermal Patches (Mylan) previously supplied under Section 29 (PDF, 3 pages, 180 KB) |
19/06/2023 | Monitoring |
![]() |
06/06/2023 | Dear Healthcare Professional Letter | Fentanyl Sandoz Transdermal patch – Product Labelling and Data Sheet updates (PDF, 4 pages, 260 KB) |
30/05/2023 | Dear Healthcare Professional Letter | Sodium valproate (Epilim) use in people who can father children: important new safety information (PDF, 2 pages, 157 KB) |
30/05/2023 | Alert | Sodium valproate (Epilim) use in people who can father children: important new safety information |